Those with Down syndrome have increased joint mobility and laxity. They are able to move at their joints in extreme ways.

All lives are enriched by relationships and interdependence, and the lives of children with disabilities are no different.

Children’s Hospital of Philadelphia (CHOP) today announced receipt of a $750,000 grant through TD Bank’s TD Ready Challenge.

The US Food and Drug Administration has granted accelerated approval to two novel drugs to treat sickle cell disease.

Jake Orlick, an 11-year-old boy, is fighting a courageous battle against Ewing Sarcoma, a rare form of bone cancer. Our Patrick Grohar, MD, PhD, an attending physician with the Cancer Center and the Director of Translational Research with the Center of Childhood Cancer Research, may be on the verge of a breakthrough with a novel new experimental treatment for relapsed Ewing sarcoma.

Patrick Grohar, MD, PhD, an attending physician with the Cancer Center and the Director of Translational Research with the Center of Childhood Cancer Research, is set to launch a novel, experimental approach to treating relapsed Ewing sarcoma, as highlighted in this story in the Philadelphia Inquirer.

Children’s Hospital of Philadelphia views diversity as a key driver of achievement, particularly when innovation is critical.

CHOP’s Food Allergy Center was one of the research sites that helped test and develop the new drug.

The Cardiac Center at Children’s Hospital of Philadelphia (CHOP) participated in the annual Pediatric Cardiac Intensive Care Society (PCICS) Conference.

Caregiver burnout is not only normal, but inevitable. A CHOP psychologist offers advice for struggling families.